Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 57.41
-0.10 (-0.17%)
At close: Jun 2, 2026
SHA:688253 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 89.82 | 144.47 | 246.86 | 173.95 | 150.68 | 120.25 |
Depreciation & Amortization | 26.53 | 26.53 | 21.78 | 25.46 | 19.06 | 13.21 |
Other Amortization | 9.49 | 9.49 | 7.91 | 7.46 | 6.66 | 5.89 |
Loss (Gain) From Sale of Assets | - | - | -0.01 | -0 | -0.01 | - |
Asset Writedown & Restructuring Costs | 2.21 | 2.21 | 0.11 | 19.54 | - | 0.61 |
Loss (Gain) From Sale of Investments | -25.36 | -25.36 | -32.03 | -26.08 | -7.09 | -2.46 |
Provision & Write-off of Bad Debts | -7.24 | -7.24 | 4.04 | 4.91 | 6.17 | - |
Other Operating Activities | -84.1 | 5.89 | 7.97 | 25.51 | 1.6 | 0.04 |
Change in Accounts Receivable | 37.12 | 37.12 | 47.27 | 48.71 | -193.74 | 18.62 |
Change in Inventory | -18.11 | -18.11 | 14.01 | -12.42 | -31.83 | -6.13 |
Change in Accounts Payable | 9.8 | 9.8 | -9.46 | 0.37 | 174.7 | -44.3 |
Change in Other Net Operating Assets | 9.8 | 9.8 | 6.15 | 1.72 | - | - |
Operating Cash Flow | 48.49 | 193.13 | 305.46 | 259.85 | 126.43 | 106.27 |
Operating Cash Flow Growth | -83.63% | -36.77% | 17.55% | 105.53% | 18.97% | -83.39% |
Capital Expenditures | -24.66 | -31.13 | -36.16 | -16.97 | -57.71 | -63.75 |
Sale of Property, Plant & Equipment | 0.14 | 0.15 | 0.26 | 0 | - | 0 |
Cash Acquisitions | -4 | -4 | - | - | - | - |
Investment in Securities | 128.16 | 203.19 | -26.11 | -410.95 | -1,037 | 22.78 |
Other Investing Activities | -1.21 | 0.5 | -1 | - | 8.82 | 1.7 |
Investing Cash Flow | 98.43 | 168.71 | -63.01 | -428.92 | -1,086 | -39.27 |
Short-Term Debt Issued | - | - | - | - | 17.57 | - |
Total Debt Issued | - | - | - | - | 17.57 | - |
Short-Term Debt Repaid | - | - | - | - | - | -8.29 |
Long-Term Debt Repaid | - | -4.21 | -3.55 | -20.83 | -3.05 | -1.19 |
Total Debt Repaid | -4.21 | -4.21 | -3.55 | -20.83 | -3.05 | -9.48 |
Net Debt Issued (Repaid) | -4.21 | -4.21 | -3.55 | -20.83 | 14.52 | -9.48 |
Issuance of Common Stock | 6.66 | 6.66 | 5.25 | - | 820.07 | - |
Repurchase of Common Stock | -28 | -28 | -50.01 | - | - | - |
Common Dividends Paid | -75.23 | -75.23 | -54.42 | -22.64 | -0.22 | -50.07 |
Other Financing Activities | 28.22 | - | - | -1 | -18.59 | - |
Financing Cash Flow | -72.56 | -100.79 | -102.74 | -44.48 | 815.78 | -59.55 |
Foreign Exchange Rate Adjustments | -3.03 | -1.7 | 1.56 | 1.33 | 42.65 | -9.76 |
Net Cash Flow | 71.33 | 259.35 | 141.27 | -212.21 | -101.07 | -2.3 |
Free Cash Flow | 23.82 | 162 | 269.31 | 242.89 | 68.71 | 42.52 |
Free Cash Flow Growth | -90.92% | -39.84% | 10.88% | 253.47% | 61.59% | -92.45% |
Free Cash Flow Margin | 7.36% | 38.39% | 43.34% | 50.81% | 15.38% | 13.01% |
Free Cash Flow Per Share | 0.17 | 1.19 | 1.98 | 1.79 | 0.56 | 0.42 |
Cash Income Tax Paid | 18.09 | 46.07 | 90.94 | 45.98 | 33.76 | 42.72 |
Levered Free Cash Flow | 9.06 | 126.56 | 212.9 | 178.62 | 44.72 | -7.06 |
Unlevered Free Cash Flow | 9.17 | 126.66 | 212.97 | 178.75 | 44.97 | -6.98 |
Change in Working Capital | 37.14 | 37.14 | 48.84 | 29.1 | -50.64 | -31.28 |